未登录

Y

Yung Sang Lee

university of ulsan

H指数:42

被引数:6,305

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Tenofovir Alafenamide for Drug-Resistant Hepatitis B: A Randomized Trial for Switching From Tenofovir Disoproxil Fumarate

替诺福韦艾拉酚胺治疗耐药乙型肝炎: 从富马酸替诺福韦酯转换的随机试验

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY

IF12

2022-02-0149

PRE

The role of muscle depletion and visceral adiposity in HCC patients aged 65 and over undergoing TACE

IF3.4

2021-10-3013

OAAI

Variceal bleeding is aggravated by portal venous invasion of hepatocellular carcinoma: a matched nested case-control study

IF3.4

2021-01-0531

OAAI

Development of machine learning-based clinical decision support system for hepatocellular carcinoma

SCIENTIFIC REPORTS

IF3.9

2020-09-0928

OAAI

Monotherapy with tenofovir disoproxil fumarate for adefovir-resistant vs. entecavir-resistant chronic hepatitis B: A 5-year clinical trial

JOURNAL OF HEPATOLOGY

IF33

2019-07-0136

PREAI

Factors and models for predicting posthepatectomy liver failure in patients undergoing hepatic resection for hepatocellular carcinoma

JOURNAL OF HEPATOLOGY

IF33

2019-04-010

PREAI

Comparison of surgical resection versus transarterial chemoembolization with additional radiation therapy in patients with hepatocellular carcinoma with portal vein invasion

CLINICAL AND MOLECULAR HEPATOLOGY

IF16.9

2018-06-2512

OAAI

Clinical features and outcomes of patients with hepatocellular carcinoma complicated with bile duct invasion

CLINICAL AND MOLECULAR HEPATOLOGY

IF16.9

2017-06-2543

OAAI

Clinical significance of fatty liver disease induced by tamoxifen and toremifene in breast cancer patients

IF7.9

2016-08-0136

PREAI

Comprehensive Outcomes of On- and Off-Antiviral Prophylaxis in Hepatitis B Patients Undergoing Cancer Chemotherapy: A Competing Risks Analysis

JOURNAL OF MEDICAL VIROLOGY

IF4.6

2016-04-0512

PREAI

Clinical characteristics and potential aetiologies of non-B non-C hepatocellular carcinoma in hepatitis B virus endemic area

LIVER INTERNATIONAL

IF5.2

2016-03-2418

PREAI

Intimate association of visceral obesity with non-alcoholic fatty liver disease in healthy Asians: A case-control study

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

IF3.4

2015-10-1238

PREAI

Response to Letter Regarding Article, Prevalence and Prediction of Coronary Artery Disease in Patients With Liver Cirrhosis: A Registry-Based Matched Case-Control Study

IF38.6

2015-07-140

OAAI

Optimal methods for measuring eligibility for liver transplant in hepatocellular carcinoma patients undergoing transarterial chemoembolization

JOURNAL OF HEPATOLOGY

IF33

2015-05-0117

PREAI

Prevalence and Prediction of Coronary Artery Disease in Patients With Liver Cirrhosis A Registry-Based Matched Case-Control Study

IF38.6

2014-10-1484

PREAI

Clinical Usefulness of Endoscopic Palliation in Patients with Biliary Obstruction Caused by Hepatocellular Carcinoma

IF3.6

2013-08-098

PREAI

Randomized Trial of the Virologic Response during up to Two Years of Entecavir-Adefovir Combination Therapy in Multiple-Drug-Refractory Chronic Hepatitis B Virus Patients

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

2013-07-0110

OAAI

Half-Life of Serum Alpha-Fetoprotein An Early Prognostic Index of Recurrence and Survival After Hepatic Resection for Hepatocellular Carcinoma

ANNALS OF SURGERY

IF6.4

2013-04-0119

PREAI

Recurrences of hepatocellular carcinoma following complete remission by transarterial chemoembolization or radiofrequency therapy: Focused on the recurrence patterns

HEPATOLOGY RESEARCH

IF3.4

2013-02-2639

PREAI

Clinical course of chronic hepatitis B patients who were off-treated after lamivudine treatment: analysis of 138 consecutive patients

VIROLOGY JOURNAL

IF3.8

2012-10-1819

OAAI